Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 190

    Thailands legislature legalizes medical use of marijuana

    Thailand's legislature legalizes medical use of marijuana

    Medical Dialogues Bureau26 Dec 2018 9:00 AM IST
    Recreational use of marijuana remains illegal and subject to prison terms and fines commensurate with the quantities involved.Bangkok: Thailand's...
    Aurobindo Pharma gets USFDA nod for Vecuronium Bromide Injection

    Aurobindo Pharma gets USFDA nod for Vecuronium Bromide Injection

    Medical Dialogues Bureau25 Dec 2018 9:30 AM IST
    Aurobindo Pharma said the product, used as part of general anaesthesia to provide skeletal muscle relaxation during surgery or mechanical ventilation,...
    Dr Reddys launches Aspirin and Dipyridamole capsules in US market

    Dr Reddy's launches Aspirin and Dipyridamole capsules in US market

    Medical Dialogues Bureau25 Dec 2018 9:15 AM IST
    Quoting IMS Health data, Dr Reddy's Laboratories said the Aggrenox brand and generic had US sales of approximately USD 182 million for the most recent...
    Shanghai Junshi Biosciences soars 21 percent on Hong Kong debut

    Shanghai Junshi Biosciences soars 21 percent on Hong Kong debut

    Medical Dialogues Bureau25 Dec 2018 9:00 AM IST
    Shanghai-based Junshi Biosciences has a pipeline of 13 biologic drug candidates, including immuno-oncology drugs and drugs targeting metabolic and...
    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

    Medical Dialogues Bureau24 Dec 2018 9:30 AM IST
    Mumbai: Pharma major Lupin and global biopharmaceutical company AbbVie Inc., announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated...
    Zydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets,Febuxostat tablets

    Zydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets,Febuxostat tablets

    Medical Dialogues Bureau24 Dec 2018 9:15 AM IST
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Doxycycline Hyclate delayed-release tablets, used to treat...
    Novartis to buy France

    Novartis to buy France's CellforCure to boost cell, gene therapy

    Medical Dialogues Bureau24 Dec 2018 9:00 AM IST
    Novartis, which already has an agreement with CellforCure to help make Kymriah, said it aims to add CellforCure's facilities to a similar factory in...
    Aurobindo Pharma gets USFDA nod for Potassium Chloride extended-release tablets

    Aurobindo Pharma gets USFDA nod for Potassium Chloride extended-release tablets

    Medical Dialogues Bureau23 Dec 2018 9:59 AM IST
    "The company has received final approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended-release tablets in the...
    Torrent Pharma issues voluntary nationwide recall of Losartan Potassium tablets: USFDA

    Torrent Pharma issues voluntary nationwide recall of Losartan Potassium tablets: USFDA

    Farhat Nasim23 Dec 2018 9:45 AM IST
    New Delhi: Indian pharmaceutical major, Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets in the US market...
    USFDA panel backs prescribing NALOXONE along with painkillers

    USFDA panel backs prescribing NALOXONE along with painkillers

    Medical Dialogues Bureau23 Dec 2018 9:15 AM IST
    The prescription of naloxone could facilitate a healthy dialogue between patients and the healthcare provider, Maryann Amirshahi, a panel member who...
    Pharma industry returns on R&D investment hit 9-year low

    Pharma industry returns on R&D investment hit 9-year low

    Medical Dialogues Bureau23 Dec 2018 9:00 AM IST
    An annual survey of the economics of pharma research and development (R&D) by the consultancy found that despite a steady flow of new medicines...
    Another trouble for J&J: CDSCO seize samples of baby products for testing

    Another trouble for J&J: CDSCO seize samples of baby products for testing

    Farhat Nasim22 Dec 2018 12:14 PM IST
    The action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok